Financial Summary (All numbers in INR Mn) 

Financial and Business Summary for Q2FY27

§  Revenue from Operations of Q2FY27 stood at INR 15,600 Mn, a growth of 20% YoY, Revenue share from the North America is 72% in Q2FY27 as compared to 76% in Q2FY26 and from the Europe is 16% in Q2FY27 as compared to 12% in Q2FY26.

§  Finished dosages (FD), Active Pharmaceuticals Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Peptides CDMO contribute 73%, 13%, 10% and 3% of revenue from operations respectively for Q2FY27.

§  ROCE is at 17.6% in Q2FY27 in par with FY26.

§  Closed the quarter with a net cash position of ₹8,280 million, compared with net debt of ₹1,012 million in Q1 FY27.

Commenting on the results, Dr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “Our Quarterly revenue has crossed ₹1500 Cr in Q2 FY27 with EBITDA of ₹338 Cr, despite higher input and logistics costs from tensions in West Asia. Cost pressures will persist and we are working with customers to manage them with a lag. We filed two potential first-to-file ANDAs in H1, which makes it a total of three potential first to file ANDAs and continue to shift towards complex generics and peptide CDMO. With the balance warrant proceeds received, we hold net cash of ₹828 Cr to invest in R&D, manufacturing and quality”.

The inauguration was led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India, Mrs. Uma Chigurupati, Executive Director, Granules India Limited & Prof. B S Murty, Director, IITH.

Ascelis Center of Excellence for Peptide Development and Characterization, established under Ascelis Peptides, the CDMO arm of Granules, this Centre will drive the development of cosmetic, therapeutic, and pharmaceutical peptides. It is Ascelis’ first development and characterization facility in India and is equipped for primary, secondary, and tertiary structure characterization. The Center brings advanced analytical and process development capabilities in-house and will work in collaboration with our Swiss-based R&D facility Senn Chemicals, strengthening the group’s integrated global peptide offering and reducing reliance on external partners.

Granules Center of Excellence for Particle Engineering, This Centre will advance polymorph research, material science, and novel drug delivery systems, including amorphous solid dispersions. It replaces earlier external and ad-hoc development with a dedicated research platform that enables first-to-file opportunities, enhances formulation performance, and supports the creation of proprietary technologies for regulated markets.

This activity is part of the Pradhan Mantri TB Mukt Bharat Abhiyaan, a national programme launched by the Government of India aimed at eliminating TB by 2025. Granules India Limited is registered as Nikshay Mitra with Ministry of Health & Family Welfare, Government of India. The project will be carried out with the Akshaya Patra Foundation as the implementation partner.

This initiative comes at a critical time, as India bears the world’s highest tuberculosis burden, accounting for nearly 27% of the global incidence. According to the Global TB Report 2023, an estimated 2.82 million new TB cases occurred in India in 2022, with approximately 331,000 deaths attributed to the disease.

The inaugural ceremony was held at the District Collectorate, Bhadradri Kothagudem, and was graced by Shri Jitesh V Patil, IAS, District Collector and Magistrate of Bhadradri Kothagudem, and Mrs. Uma Chigurupati, Executive Director, Granules India Limited.

Speaking at the event, Ms Uma Chigurupati said, “At Granules, we believe that good health is not just a basic right but the foundation for a prosperous and productive society. Through this initiative, we are committed to supporting TB patients with essential nutritional support, which plays a crucial role in their recovery journey. We are proud to contribute to the Pradhan Mantri TB Mukt Bharat Abhiyaan and play our part in India’s mission to eliminate TB by 2025.”

EcoVadis is one of the world’s trusted providers of business sustainability ratings, assessing companies  on environment, labour & human rights, ethics, and sustainable procurement. This recognition affirms Granules’ robust sustainability practices and transparency in its business operations.

The company’s first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence across its manufacturing footprint. The rating reflects the company’s purpose-driven transformation journey — Healing lives responsibly through pioneering green science — and aligns with its broader sustainability goals, including science-based climate targets, greener chemistry platforms, and safer workplace practices.

“This Gold rating is more than a recognition — it’s a reminder that we are choosing to grow differently by placing sustainability at the heart of our progress,” said Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India. “It is a moment of pride, but also one of responsibility to continue raising the bar as we build a more resilient and responsible future.”

Priyanka Chigurupati, Executive Director, added: “We deeply value the trust and partnership of our customers and suppliers. This milestone is a shared win — a testament to what’s possible when we act together with ‘One Planet, One Purpose’.”

Women police officers dedicate their lives to safeguarding communities, often putting their health on the back burner. With demanding and high stress working hours, they often struggle to prioritize preventive healthcare. Recognizing this, Granules India’s ‘Breast Health Express’ initiative raised awareness about breast health, empowering them with knowledge of regular self-examination and cancer screening services while promoting the importance of early detection. The camp offered breast health screenings and awareness sessions for 100 women police officials.

Since its launch in September 2024, the mobile screening unit has conducted 18 camps, screening over 1,000 women and reaching more than 2,000 individuals through educational sessions. The initiative brings together the collective efforts of Granules India Ltd, AIG Hospitals, Asian Medical Foundation, and UC Breast Foundation. This multi-organizational approach integrates medical expertise, state-of-the-art mobile unit with mammography and ultrasound capabilities and facilities for essential health checks such as haemoglobin and blood pressure, and community outreach to enhance healthcare accessibility for women in underserved communities.

Dr Jitendra IPS, Director General of Police, Telangana State, lauded the initiative, stating, “One of the biggest challenges with breast cancer is late detection. However, women in demanding professions like law enforcement often prioritize duty over personal health, leading to delayed screenings. Early detection drastically improves treatment success and recovery. I strongly urge every woman above 40 to undergo a breast cancer screening annually or at least every alternate year. This initiative by Granules India and AIG Hospitals is a commendable step in ensuring our women officers receive the preventive healthcare they deserve. By prioritizing early detection, we can safeguard the health and well-being of women across Telangana.”

Dr. Pragnya Chigurupati, Consultant Breast Oncologist at AIG Hospitals and Founder of UC Breast Foundation, highlighted the urgency of breast cancer awareness, stating, “India, more so Telangana, continues to witness an alarming rise in the number of breast cancer cases. ‘Breast Health Express’ aims to bring early detection closer to the homes of women via mammogram and ultrasound screening. Through the UC Breast Foundation, we would be able to provide financial assistance to those women who need treatment for breast issues.”

Mrs. Uma Chigurupati, Executive Director of Granules India Ltd, has been a key driving force behind the company’s CSR efforts, ensuring that initiatives like Breast Health Express focus on making breast cancer prevention accessible to all women.  Her leadership has been instrumental in shaping Granules India’s vision for community health and well-being.